What pathways and diseases are currently covered for the qBiomarker Somatic Mutation PCR Arrays?

The pathways covered include major receptor tyrosine kinase pathways, non-receptor kinase pathways, as well as additional oncogene and tumor suppressor pathways; and the targeted diseases include all major cancer types. In addition, a collection of more than 800 pre-validated somatic mutation assays enables researchers to study single mutations or to customize the mutation panels or collections according to their research needs.

Can’t find what you are looking for?

Browse the FAQ base with our FAQ search.